锝[99mTc]比西酯(Technetium Tc-99M Bicisate Kit) - 在研适应症：中枢神经系统创伤，脑疾病_专利_临床

概要

基本信息

药物类型

小分子化药、诊断用放射药物

别名

99mTc-Bicisate、99mTc-Ethyl Cysteinate Dimer、[N,N'-Ethylenedi-L-Cysteinate(3-)] Oxotechnetium (99mTc)-Diethyl Ester

+ [9]

靶点-

作用机制

SPECT(单光子发射计算机断层成像术增强剂)

治疗领域

神经系统疾病其他疾病

在研适应症

中枢神经系统创伤脑疾病

非在研适应症-

原研机构

Lantheus Medical Imaging, Inc.

在研机构

PDRadiopharma, Inc.Lantheus Medical Imaging, Inc.

非在研机构-

最高研发阶段批准上市

首次获批日期

日本 (1994-01-19),

脑疾病

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

结构

分子式C12H21N2O5S2Tc

InChIKeyVCBQYKUJYSGWGD-NGAFWABFSA-N

CAS号121281-41-2

关联

1

项与锝[99mTc]比西酯相关的临床试验

NCT02513992 / WithdrawnN/AIIT

Early Ictal SPECT With Intra-arterial Injection to Localize the Ictal Onset Zone in Refractory Focal Epilepsy.

Ictal SPECT with intravenous injection in a cubital vein of a perfusion tracer is an established technique to localize the ictal onset zone during presurgical evaluation of refractory focal epilepsy. When seizures last less than 10 seconds, localizing information is often not obtained. Since it takes around 30 seconds before the tracer reaches the brain after intravenous injection, ictal hyperperfusion most likely has already switched to postictal hypoperfusion. In this study, we plan to inject the perfusion tracer in the aorta proximal to the cerebral arteries, which will allow a true ictal injection in patients with seizures of short duration.

开始日期2016-05-01

申办/合作机构-

100 项与锝[99mTc]比西酯相关的临床结果

登录后查看更多信息

100 项与锝[99mTc]比西酯相关的转化医学

登录后查看更多信息

100 项与锝[99mTc]比西酯相关的专利（医药）

登录后查看更多信息

66

项与锝[99mTc]比西酯相关的文献（医药）

2024-06-01·Radiological physics and technology

Feasibility study of radioactivity estimation of 99mTc and 123I-labeled radiopharmaceuticals using shielded syringes

Article

作者: Nakamura, Yuto ; Yasuno, Narumi

This study investigates the feasibility of estimating the radioactivity of radiopharmaceuticals using shielded syringes. The radioactivities of ^99mTc-MDP, ^99mTc-HMDP, ^99mTc-ECD, ^99mTc-MAG₃, and ¹²³I-IMP were measured using a dose calibrator. Correlation coefficients and regression equations were obtained from the radioactivity in the shielded and unshielded syringes. ^99mTc-MDP was also measured for residual radioactivity after the administration. The correlation coefficients of ^99mTc-MDP, ^99mTc-HMDP, ^99mTc-ECD, ^99mTc-MAG₃, and ¹²³I-IMP were r_s = 0.9998, r_s = 0.9997, r_s = 0.9999, r_s = 0.9998, and r_s = 0.9888, respectively. The regression equations were y = 0.0364x + 0.0913, y = 0.0349x + 0.0273, y = 0.0343x - 0.0018, y = 0.0522x + 0.1215, and y = 0.0383x + 0.0058, respectively. The correlation coefficient for the residual radioactivity of ^99mTc-MDP was r_s = 0.9887 and the regression equation was y = 0.1505x + 0.0853. The radioactivity of ^99mTc- and ¹²³I-labeled radiopharmaceuticals in shielded syringes was accurately measured. It was suggested that the measuring shielded syringes could provide an estimate of the actual radioactivity.

2021-11-01·Clinical nuclear medicine3区 · 医学

No Evidence to Favor 99mTc-HMPAO or 99mTc-ECD for Ictal Brain Perfusion SPECT for Identification of the Seizure Onset Zone

3区 · 医学

Article

作者: Voges, Berthold ; Martens, Tobias ; Jaber, Mariam ; Klutmann, Susanne ; Lindenau, Matthias ; Buchert, Ralph ; Lanz, Michael ; Apostolova, Ivayla ; House, Patrick M ; Taherpour, Jila ; Sauvigny, Thomas ; Stodieck, Stefan

Purpose:

Ictal brain perfusion SPECT with the tracer 99mTc-HMPAO or 99mTc-ECD is widely used for identification of the epileptic seizure onset zone (SOZ) in presurgical evaluation if standard pointers are uncertain or inconsistent. For both tracers, there are theoretical arguments to favor it over the other for this task. The aim of this study was to compare the performance of ictal brain perfusion SPECT between 99mTc-HMPAO and 99mTc-ECD in a rather large patient sample.

Patients and Methods:

The study retrospectively included 196 patients from clinical routine in whom ictal perfusion SPECT had been performed with stabilized 99mTc-HMPAO (n = 110) or 99mTc-ECD (n = 86). Lateralization and localization of the SOZ were obtained by the consensus of 2 independent readers based on visual inspection of the SPECT images.

Results:

The 99mTc-HMPAO group and the 99mTc-ECD group were well matched with respect to age, sex, age at first seizure, duration of disease, seizure frequency, history of previous brain surgery, and findings of presurgical MRI. The proportion of lateralizing ictal SPECT did not differ significantly between 99mTc-HMPAO and 99mTc-ECD (65.5% vs 72.1%, P = 0.36). Sensitivity of ictal perfusion SPECT (independent of the tracer) for correct localization of the SOZ in 62 patients with temporal lobe epilepsy and at least worthwhile improvement (Engel scale ≤ III) 12 months after temporal epilepsy surgery was 63%.

Conclusions:

This study does not provide evidence to favor 99mTc-HMPAO or 99mTc-ECD for identification of the SOZ by ictal perfusion SPECT.

2020-11-01·Journal of neuroimaging : official journal of the American Society of Neuroimaging3区 · 医学

The Role of the Cerebellum in Pain Perception: A Brain SPECT Perfusion Study in Patients with Burn Injuries

3区 · 医学

Article

作者: Lewis, David H. ; Wilson, Ann ; Zacharias, Claudia ; Patterson, David ; Sharar, Sam ; Bermo, Mohammed S. ; Hoffman, Hunter ; Minoshima, Satoshi

ABSTRACT:

BACKGROUND AND PURPOSE:

Virtual reality (VR) is a promising tool for distraction analgesia. This study aims to compare brain perfusion patterns while patients were undergoing burn wound care in two conditions—VR distraction and control (NoVR).

METHODS:

With IRB approval, four patients hospitalized for acute burn care (three males and one female) participated in the study. All patients underwent wound care on two consecutive days; 1 day with standard analgesia and adjunctive VR, and the other day with standard analgesia alone, otherwise the wound care was very similar. Tc‐99m ethyl cysteinate dimer was injected during wound care at the time of peak pain. Subjective patient reports on a 0‐10 scale of pain intensity, time spent thinking about pain, and “fun” as well as opioid equivalent usage were analyzed. Voxel by voxel subtraction analysis of brain perfusion Single Photon Emission Computed Tomography (SPECT) images was performed at the group level. Statistical significance threshold was defined as P < .05.

RESULTS:

Mean group subjective scores (VR, NoVR, statistical significance, and P‐value) were observed for maximal pain intensity (9.0, 8.8, insignificant, and P = .809), time spent thinking about pain (5.2, 10.0, significant, and P = .015), and fun (6.0, 2.5, significant, and P = .012). Subtraction group analysis demonstrated VR‐induced modulation of brain activity with statistically significant relative suppression of cerebellar activation in the VR compared to intense cerebellar activation in the NoVR environments.

CONCLUSION:

Relative decrease in cerebellar perfusion based on stringent statistical threshold in the VR environment combined with improved subjective pain experience supports the hypotheses on the role of cerebellum in perception of noxious stimuli.

100 项与锝[99mTc]比西酯相关的药物交易

登录后查看更多信息

外链

KEGG	Wiki	ATC	Drug Bank
-	-	V09A	-

研发状态

10 条最早获批的记录,

登录

后查看更多信息

适应症	国家/地区	公司	日期
中枢神经系统创伤	美国	Lantheus Medical Imaging, Inc.	1994-11-23
脑疾病	日本	PDRadiopharma, Inc.	1994-01-19

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


AAIC2016	N/A	路易体病	-	123I-2β-Carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (123I-FP-CIT) dopamine transporter (DAT) SPECT	製餘襯襯積鏇憲糧遞築(襯鑰淵積繭築遞衊艱網) = 衊鹽膚製鹹構艱膚蓋餘製鏇鹽鹹遞鏇憲艱艱壓 (觸鹽憲襯襯艱築鏇範夢 )	-	2016-07-01
				123I-metaiodobenzylguanidine (MIBG) myocardial SPECT	製餘襯襯積鏇憲糧遞築(襯鑰淵積繭築遞衊艱網) = 範艱繭觸鹹齋獵簾選窪製鏇鹽鹹遞鏇憲艱艱壓 (觸鹽憲襯襯艱築鏇範夢 )